Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Proteomics International Laboratories Ltd. ( (AU:PIQ) ) is now available.
Proteomics International Laboratories Ltd has announced groundbreaking results for its OxiDx test, which can identify and assess recovery from exercise-induced muscle damage in thoroughbred racehorses. This novel test, published in the journal Veterinary Medicine and Science, offers a simple and effective solution for managing horse recovery post-race, addressing a significant gap in equine veterinary medicine. The OxiDx test, which measures oxidative stress through a dried blood spot, presents a more precise and less invasive alternative to current methods such as MRI and ultrasound. The successful study marks a significant milestone in the commercialisation of the OxiDx test, with plans for an Australian launch in late 2025 and subsequent expansion into the USA.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, a leader in precision diagnostics, focuses on developing innovative diagnostic solutions. Its subsidiary, OxiDx Pty Ltd, collaborates with The University of Western Australia to advance diagnostic technologies, particularly in the equine veterinary field.
Average Trading Volume: 300,381
Technical Sentiment Signal: Sell
Current Market Cap: A$76.93M
Find detailed analytics on PIQ stock on TipRanks’ Stock Analysis page.